A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer

<div>NIRF and ultrasound bimodal images of IR783-NBs-Affibody <i>in vitro</i>. (a) A LSCM image of IR783-NBs-Affibody. (b) The contrast-enhanced ultrasound images of IR783-NBs-Affibody, SonoVue microbubbles, and PBS <i>in vitro</i>, respectively.</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer 